Sutro Biopharma, Inc. (STRO) stock
STRONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$10.26+0.09 (+0.88%)
Close on Nov 11, 2026Market cap $170.12MP/E –Yield –
Sutro Biopharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Sutro Biopharma's enterprise value was $5.73M on Nov 11, 2026, against -$89.35M a year earlier. Over the last 5 years it ranged from -$262.85M to $523.39M, with a median of -$3.72M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.73M | – |
| 2025 | Dec 31, 2025 | -$69.13M | – |
| 2024 | Dec 31, 2024 | -$236.65M | – |
| 2023 | Dec 29, 2023 | -$52.71M | -130.4% |
| 2022 | Dec 30, 2022 | $173.37M | -66.9% |
| 2021 | Dec 31, 2021 | $523.39M | -19.4% |
| 2020 | Dec 31, 2020 | $649.05M | +363.0% |
| 2019 | Dec 31, 2019 | $140.17M | – |
| 2018 | Dec 31, 2018 | -$103.89M | – |
See a number that looks wrong?